Klencke Barbara 4
4 · TScan Therapeutics, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Klencke Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+36,524→ 36,524 totalExercise: $2.66Exp: 2033-06-12→ Voting Common Stock (36,524 underlying)
Footnotes (1)
- [F1]35,000 shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, with 1,524 shares subject to this option vesting and becoming exercisable in full on June 13, 2023, in each case subject to the Reporting Person's continued service at such time.